Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Upregulation of LncRNA FEZF-AS1 is associated with advanced clinical stages and family history of cancer in patients with NSCLC.

Pathology, research and practice - 1 Jun 2018

Gong Wei, Cao Yi, Wang Yuanyuan, Yang Lei, Su Wenpeng, Qiu Fuman, Datta Soham, Rao Boqi, Xian Jianfeng, Lin Mingzhu, Feng Yingyi, Zhang Xin, Zhou Yifeng, Gao Xingcheng, Lu Jiachun

Abstract excerpt

Antisense RNA (AS) is a type of long non-coding RNAs that functions as a post-transcriptional regulatory element on regulating parental coding gene expression via directly binding to complementary mRNA sequences. We aimed to investigate the effect of the AS to FEZF1 gene on non-small cell lung cancer (NSCLC) development. The expression level of lncRNA FEZF-AS1 and FEZF1 was determined by the quantitative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Lung Neoplasms

Share to Repressor Proteins

Share to RNA, Antisense

Share to Transcription Factors

Share to Up-Regulation

Source

Identifiers

PMID: 29709443
DOI: 10.1016/j.prp.2018.04.014

Genes

FEZF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Upregulation of LncRNA FEZF-AS1 is associated with advanced clinical stages and family history of cancer in patients with NSCLC.PMID 29709443Read ↗

FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignanciesSemantic proximity Read ↗

Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of TumorsSemantic proximity Read ↗

Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 PathwaySemantic proximity Read ↗

High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancerSemantic proximity Read ↗

AFAP1‐AS1: A novel oncogenic long non‐coding RNA in human cancersSemantic proximity Read ↗

lncRNA SLC16A1-AS1 as a Novel Prognostic Biomarker in Non-Small Cell Lung CancerSemantic proximity Read ↗

The role of long non-coding RNA FGD5-AS1 in cancerSemantic proximity Read ↗

Long noncoding RNA PXN-AS1-L promotes non-small cell lung cancer progression via regulating PXNSemantic proximity Read ↗

A promising new cancer marker: Long noncoding RNA EGFR-AS1Semantic proximity Read ↗

Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.Semantic proximity Read ↗

Long non-coding RNAs associated with non-small cell lung cancerSemantic proximity Read ↗

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83ASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.